2Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacological Reviews, 1999, 51(1): 7-61.
3Yamakura T, Shimoji K. Subunit- and site-specific pharmacology of the NMDA receptor channel. Progress in Neurobiology, 1999, 59(3): 279-298.
4Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Current Opinion in Pharmacology, 2007, 7(1): 39-47.
5Yao Y, Mayer M L. Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. The Journal of Neuroscience, 2006, 26(17): 4559- 4566.
6Matsuda K, Kamiya Y, Matsuda S, et al. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. Brain research. Molecular Brain Research, 2002, 100(1-2): 43-52.
7Williams K. lfenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Molecular Pharmacology, 1993, 44(4): 851-859.
8Paoletti P, Ascher P, Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. The Journal of Neuroscience, 1997, 17(15): 5711-5725.
9Feng B, Morley R M, Jane D E, et al. The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology, 2005, 48(3): 354-359.
10Liu L, Wong T P, Pozza M F, et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science, 2004, 304(5673): 1021-1024.
